← back to search

Tom Eirik Mollnes

Oslo University Hospital · NO
Area of research
Immunology · Hematology
Research interest
Research interests include Complement system in diseases, Immune Response and Inflammation, Blood Coagulation and Thrombosis Mechanisms, and Blood groups and transfusion.
h-index
73
citations
21,972
works
689
NIH funding
primary concept
email

Recent publications

Prevalence and Characteristics Associated With Post–COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults
JAMA Network Open 2023cited by 118position: middledoi
Heme Interferes With Complement Factor I-Dependent Regulation by Enhancing Alternative Pathway Activation
Frontiers in Immunology 2022cited by 23position: middledoi
The lytic polysaccharide monooxygenase CbpD promotes Pseudomonas aeruginosa virulence in systemic infection
Nature Communications 2021cited by 97position: middledoi
A Complement C3–Specific Nanobody for Modulation of the Alternative Cascade Identifies the C-Terminal Domain of C3b as Functional in C5 Convertase Activity
The Journal of Immunology 2020cited by 22position: middledoi
Effects of gamma radiation sterilization on the structural and biological properties of decellularized corneal xenografts
Acta Biomaterialia 2019cited by 66position: middledoi
‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development
Nature Immunology 2019cited by 17position: middledoi
Staphylococcus aureus Membrane-Derived Vesicles Promote Bacterial Virulence and Confer Protective Immunity in Murine Infection Models
Frontiers in Microbiology 2018cited by 68position: middledoi
Alginate microbeads are coagulation compatible, while alginate microcapsules activate coagulation secondary to complement or directly through FXII
Acta Biomaterialia 2017cited by 26position: middledoi
Complement activation by cholesterol crystals triggers a subsequent cytokine response
Molecular Immunology 2016cited by 45position: middledoi
Sensitive, reliable and easy-performed laboratory monitoring of eculizumab therapy in atypical hemolytic uremic syndrome
Clinical Immunology 2015cited by 54position: lastdoi
A novel method for direct measurement of complement convertases activity in human serum
Clinical & Experimental Immunology 2014cited by 43position: middledoi
Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission
Clinical & Experimental Immunology 2014cited by 42position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 3 papers (2014–2015)Lambertus P. van den Heuvel · KU Leuven3 papers (2014–2015)Fatemeh Askarian · University of California San Diego2 papers (2018–2021) · 2 papers (2014–2015)Per H. Nilsson · University of Oslo2 papers (2019–2022)Satoshi Uchiyama · National Cancer Center Hospital East2 papers (2018–2021)Alessandra Zarantonello · Aarhus University2 papers (2020–2022)Victor Nizet · CNR de la Résistance aux Antibiotiques2 papers (2018–2021)Terje Espevik · Gene Therapy Laboratory2 papers (2016–2017)John D. Lambris · California University of Pennsylvania2 papers (2017–2019) · 2 papers (2014–2015)Anna M. Blom · Lund University2 papers (2014–2019) · 2 papers (2018–2021) · 2 papers (2014–2015) · 1 papers (2017–2017) · 1 papers (2022–2022) · 1 papers (2021–2021) · 1 papers (2017–2017)V. Michael Holers · University of Colorado Anschutz Medical Campus1 papers (2019–2019) · 1 papers (2018–2018)